Journal
European journal of nuclear medicine and molecular imaging
Publication Date
6-1-2022
Volume
49
Issue
7
First Page
2323
Last Page
2341
Document Type
Open Access Publication
DOI
10.1007/s00259-022-05780-2
Rights and Permissions
Lopci, E., Hicks, R.J., Dimitrakopoulou-Strauss, A. et al. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0. Eur J Nucl Med Mol Imaging 49, 2323–2341 (2022). https://doi.org/10.1007/s00259-022-05780-2 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Lopci, E; Hicks, R J; Dimitrakopoulou-Strauss, A; Dercle, L; Iravani, A; Seban, R D; Sachpekidis, C; Humbert, O; Gheysens, O; Glaudemans, A W J M; Weber, W; Wahl, R L; Scott, A M; Pandit-Taskar, N; and Aide, N, "Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0." European journal of nuclear medicine and molecular imaging. 49, 7. 2323 - 2341. (2022).
https://digitalcommons.wustl.edu/oa_4/802
